Home  other menu  FAQ
Q: Have AbbVie's Terms and Conditions been changed to incorporate Exclusive Sourcing Agreement?
A: Yes. The Terms and Conditions of Sale of each of the Divisions/Business Units included have been changed appropriately to incorporate Wholesaler/Distributor adherence to this agreement.
Q: What is the geographic scope of the policy?
A: The scope of the agreement currently applies to entities within the 50 United States (excluding U.S. territories and Puerto Rico) and for specific countries outside the U.S. where ESA's have been implemented. We are monitoring international markets and will work closely with wholesalers/distributors and customers in taking further action, as appropriate, to ensure the integrity of AbbVie products and patient safety throughout the world.
Q: Why has AbbVie initiated this agreement?
A: Discoveries of counterfeit product in the worldwide distribution channel have highlighted risks to patients, healthcare providers, and customers who have always recognized AbbVie as providing high-quality products. The safety and integrity of AbbVie products are of the highest priority and the threat posed to public health and safety by counterfeit products is taken very seriously. Accordingly, AbbVie has undertaken this initiative domestically to help prevent any unsafe products from being introduced into the supply chain.

Security Code:*
Darou Darman Sepehr Address :
No.3(Darya Bldg), Sasanipour St, Ahmadi Roshan(Ketabi) Sq, Golnabi St, Shariati St ,Tehran, Iran
Tel :
+98 21 22921983
Fax :
+98 21 26402910
© copyright 2016 Darou Darman Sepehr Co ALL RIGHTS RESERVED